Skip to content
Novateor Research Laboratories logo

Novateor Research Laboratories

542771 BSE
₹43.00

Close ·

P/E
Not meaningful: loss-making over the last twelve months
View as Markdown
MCP
Close 26 Oct 2026 ₹43.00 +17.90 +71.3% since 18 Nov 2025
Start ₹25.10

Key Fundamentals

SMEPersonal ProductsFMCG

Price-based figures at the close · TTM

ROCE
1.67%
Debt to Equity
0.09
EPS (TTM)
₹0.00
Book Value
₹18.51
Market Cap
—
P/E (TTM)
Not meaningful: loss-making over the last twelve months
P/B
2.32
ROE
0.91%
Dividend Yield
0.00%
EBITDA
₹40.00 L
52W High
₹43.00
52W Low
₹20.08

Key Insights

Strengths

1
  • Company is almost debt free.

Weaknesses

4
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 0.72% over last 3 years.
  • Company has high debtors of 269 days.
  • Promoter holding has decreased over last 3 years: -10.1%

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bullish4312
OscillatorsBearish432
Moving AveragesStrong Bullish0010

Key readings

RSI (14)
63.87
Neutral
MACD (12,26,9)
1.66
Bullish
SMA (50)
34.83
Bullish
SMA (200)
28.97
Bullish

As of , the latest day with price data, so these readings are not current.

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.

Revenue

Revenue growth by window
10Y+43.99%
5Y+82.34%
3Y+44.86%
1Y+37.77%

Net profit

Net profit growth by window
10YZero base
5Y+58.49%
3Y+35.72%
1Y+25.00%

Operating cash flow

Operating cash flow growth by window
10YTurned negative
5YOutflow narrowed by ₹0.09 Cr
3YOutflow narrowed by ₹0.79 Cr
1YOutflow narrowed by ₹0.85 Cr

Operating margin· change in pp

Operating margin growth by window
10Y+7.39 pp
5Y+171.07 pp
3Y+24.37 pp
1Y+2.43 pp

Trailing twelve months: Results are not reported for each of the last eight quarters, so there is no trailing-twelve-month figure.

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹0.14 Cr
Mar 2018₹0.09 Cr
Mar 2019₹0.41 Cr
Mar 2020₹0.39 Cr
Mar 2021₹0.19 Cr
Mar 2022₹0.74 Cr
Mar 2023₹1.26 Cr
Mar 2024₹1.21 Cr
Mar 2025₹2.78 Cr
Mar 2026₹3.83 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017₹0.00 Cr
Mar 2018₹0.00 Cr
Mar 2019₹0.22 Cr
Mar 2020−₹0.01 Cr
Mar 2021₹0.01 Cr
Mar 2022−₹0.23 Cr
Mar 2023₹0.04 Cr
Mar 2024₹0.03 Cr
Mar 2025₹0.08 Cr
Mar 2026₹0.10 Cr

Half-yearly Results

₹ Cr
542771 half-yearly results, ₹ crore
Particulars Sep 2020Mar 2021Sep 2021Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Sales
0.07
0.12
0.28
0.46
0.82
0.44
0.36
0.85
0.79
1.98
2.47
1.36
Expenses
0.16
0.36
0.35
0.57
1.01
0.58
0.53
1
0.9
2
2.59
1.35
Operating Profit
−0.09
−0.24
−0.07
−0.11
−0.19
−0.14
−0.17
−0.15
−0.11
−0.02
−0.12
0.01
OPM %
−128.57%
−200%
−25%
−23.91%
−23.17%
−31.82%
−47.22%
−17.65%
−13.92%
−1.01%
−4.86%
0.74%
Other Income
0
0.44
−0.21
0.22
0.24
0.25
0.24
0.24
0.24
0.24
0.25
0.24
Interest
0
0
0
0
0
0.03
0.02
0.01
0.02
0.05
0.05
0.04
Depreciation
0.05
0.05
0.05
0.04
0.04
0.04
0.04
0.04
0.06
0.1
0.09
0.09
PBT
−0.14
0.15
−0.33
0.07
0.01
0.04
0.01
0.04
0.05
0.07
−0.01
0.12
Tax %
0%
0%
0%
−42.86%
0%
0%
0%
0%
20%
28.57%
100%
8.33%
Net Profit
−0.13
0.15
−0.33
0.1
0.01
0.03
0.01
0.04
0.03
0.05
−0.02
0.12
EPS (₹)
−0.27
0.31
−0.68
0.21
0.02
0.06
0.02
0.08
0.06
0.1
−0.03
0.2

Profit & Loss

₹ Cr
542771 profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
0.02
0.1
0.14
0.09
0.41
0.39
0.19
0.74
1.26
1.21
2.78
3.83
Expenses
0.02
0.11
0.08
0.04
0.13
0.53
0.52
0.92
1.6
1.54
2.92
3.93
Operating Profit
0
−0.01
0.06
0.05
0.28
−0.14
−0.33
−0.18
−0.34
−0.33
−0.14
−0.1
OPM %
0%
−10%
42.86%
55.56%
68.29%
−35.9%
−173.68%
−24.32%
−26.98%
−27.27%
−5.04%
−2.61%
Other Income
0
0.01
0.02
0.03
0.11
0.27
0.44
0.01
0.49
0.49
0.48
0.49
Interest
0
0
0.01
0.01
0
0.01
0
0
0.02
0.03
0.07
0.09
Depreciation
0
0
0.07
0.07
0.1
0.1
0.1
0.09
0.09
0.08
0.16
0.19
PBT
0
0
0
0
0.29
0.02
0.01
−0.26
0.04
0.05
0.11
0.11
Tax %
—
—
—
—
24.14%
150%
0%
−11.54%
0%
40%
27.27%
18.18%
Net Profit
0
0
0
0
0.22
−0.01
0.01
−0.23
0.04
0.03
0.08
0.1
EPS (₹)
0
0
0
0
0.74
−0.02
0.02
−0.48
0.08
0.06
0.17
0.17
Div. Payout %
—
—
—
—
0%
0%
0%
0%
0%
0%
0%
0%

Balance Sheet

₹ Cr
542771 balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
0.05
0.05
0.05
0.05
2.96
4.83
4.83
4.83
4.83
4.83
4.83
6.05
Reserves
0.88
0.88
0.88
0.88
1.11
3.73
3.74
3.01
3.04
3.93
5.71
5.45
Borrowings
0.75
0.76
0.87
0.82
0.01
0
0.24
0.24
0.84
1.11
0.91
1.03
Other Liabilities
0.11
0.15
0.1
0.09
0.24
0.23
0.17
0.06
0.24
0.59
1.16
1.74
Total Liabilities
1.79
1.84
1.9
1.84
4.32
8.79
8.98
8.14
8.95
10.46
12.61
14.27
Fixed Assets
1.59
1.64
1.66
1.59
3.55
3.45
3.36
1.94
1.78
2.43
3.41
3.24
CWIP
0
0
0
0
0
0
0
0
0.43
0.44
0
0
Investments
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Other Assets
0.19
0.19
0.23
0.24
0.76
5.33
5.61
6.19
6.73
7.58
9.19
11.02
Total Assets
1.79
1.84
1.9
1.84
4.32
8.79
8.98
8.14
8.95
10.46
12.61
14.27

Cash Flow

₹ Cr
542771 cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0
0
0.01
0.05
−0.07
−3.42
−0.27
−0.97
−0.97
−0.98
−1.03
−0.18
Investing
0
0
−0.01
0
−1.96
−0.1
−0.09
0.91
0.13
−0.25
−0.22
−0.5
Financing
0
0
0
−0.03
2.03
4.18
0.32
−0.13
0.58
1.1
1.43
0.89
Net Cash Flow
0
0
−0.01
0.02
0
0.67
−0.04
−0.18
−0.26
−0.13
0.18
0.2
Free Cash Flow
0
0
0
0.05
−2.03
−3.52
−0.36
−0.06
−1.33
−1.72
−1.73
−0.2
CFO/EBITDA
—
0
17
100
0
2,443
82
539
285
297
736
180

Ratios

542771 financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
365
219
183
243
134
234
384
212
203
338
272
269
Inventory Days
4,380
438
1,460
2,738
6,448
701
852
344
215
269
151
152
Days Payable
1,460
292
730
1,095
1,460
14.6
104
20.66
61.47
207
177
209
Cash Conversion Cycle
3,285
365
913
1,886
5,122
920
1,132
536
356
399
246
212
Working Capital Days
1,278
110
287
527
463
4,118
9,067
2,747
1,605
1,879
951
771
ROCE %
0%
0%
0.57%
0.56%
9.95%
0.47%
0.12%
2.49%
0.71%
0.86%
1.69%
1.67%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Novateor Research Laboratories insights

53 extracted metrics across FY15–FY26.

Shareholding Pattern

As of Sep 2026

  • Promoters 50.75%
  • Public 28.91%
  • Others 20.33%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

Frequently Asked Questions about Novateor Research Laboratories

What does Novateor Research Laboratories Ltd do?
Incorporated in 2011, Novateor Research Laboratories Ltd is in the business of Oral Care and Personal Care products.
Where is Novateor Research Laboratories Ltd (NOVATEOR) listed?
Novateor Research Laboratories Ltd trades under code 542771 on the BSE.
Which sector does Novateor Research Laboratories Ltd belong to?
Novateor Research Laboratories Ltd is classified under the Consumer Goods sector, in the Personal Care industry.
What is the 52-week high and low of Novateor Research Laboratories Ltd?
Over the last 52 weeks Novateor Research Laboratories Ltd has traded between ₹20.08 and ₹43 as of 26 Oct 2026.
What is the Return on Equity (ROE) of Novateor Research Laboratories Ltd?
Novateor Research Laboratories Ltd reported a return on equity of 0.91%. Its debt-to-equity ratio is 0.09.

Company Information

Incorporated in 2011, Novateor Research Laboratories Ltd is in the business of Oral Care and Personal Care products.

Website novateor.com
Listed 13 Sep 2019
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/542771.md for Novateor Research Laboratories Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More